194 related articles for article (PubMed ID: 29890520)
1. Overcoming Heparin-Associated RT-qPCR Inhibition and Normalization Issues for microRNA Quantification in Patients with Acute Myocardial Infarction.
Coelho-Lima J; Mohammed A; Cormack S; Jones S; Das R; Egred M; Panahi P; Ali S; Spyridopoulos I
Thromb Haemost; 2018 Jul; 118(7):1257-1269. PubMed ID: 29890520
[TBL] [Abstract][Full Text] [Related]
2. miR-941 as a promising biomarker for acute coronary syndrome.
Bai R; Yang Q; Xi R; Li L; Shi D; Chen K
BMC Cardiovasc Disord; 2017 Aug; 17(1):227. PubMed ID: 28830367
[TBL] [Abstract][Full Text] [Related]
3. Practical Procedures for Improving Detection of Circulating miRNAs in Cardiovascular Diseases.
Chen CC; Peng CC; Fan PC; Chu PH; Chang YS; Chang CH
J Cardiovasc Transl Res; 2020 Dec; 13(6):977-987. PubMed ID: 32440912
[TBL] [Abstract][Full Text] [Related]
4. Outcomes in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction Via Radial Access Anticoagulated With Bivalirudin Versus Heparin: A Report From the National Cardiovascular Data Registry.
Jovin IS; Shah RM; Patel DB; Rao SV; Baklanov DV; Moussa I; Kennedy KF; Secemsky EA; Yeh RW; Kontos MC; Vetrovec GW
JACC Cardiovasc Interv; 2017 Jun; 10(11):1102-1111. PubMed ID: 28527778
[TBL] [Abstract][Full Text] [Related]
5. Value of Serum miR-23a, miR-30d, and miR-146a Biomarkers in ST-Elevation Myocardial Infarction.
Bukauskas T; Mickus R; Cereskevicius D; Macas A
Med Sci Monit; 2019 May; 25():3925-3932. PubMed ID: 31130720
[TBL] [Abstract][Full Text] [Related]
6. Improving Accuracy of Urinary miRNA Quantification in Heparinized Patients Using Heparinase I Digestion.
Roest HP; Verhoeven CJ; de Haan JE; de Jonge J; IJzermans JN; van der Laan LJ
J Mol Diagn; 2016 Nov; 18(6):825-833. PubMed ID: 27598820
[TBL] [Abstract][Full Text] [Related]
7. Bivalirudin versus heparin in non-ST and ST-segment elevation myocardial infarction-a registry-based randomized clinical trial in the SWEDEHEART registry (the VALIDATE-SWEDEHEART trial).
Erlinge D; Koul S; Eriksson P; Scherstén F; Omerovic E; Linder R; Östlund OP; Wallentin L; Fröbert O; James S
Am Heart J; 2016 May; 175():36-46. PubMed ID: 27179722
[TBL] [Abstract][Full Text] [Related]
8. Use and Effectiveness of Bivalirudin Versus Unfractionated Heparin for Percutaneous Coronary Intervention Among Patients With ST-Segment Elevation Myocardial Infarction in the United States.
Secemsky EA; Kirtane A; Bangalore S; Jovin IS; Shah RM; Ferro EG; Wimmer NJ; Roe M; Dai D; Mauri L; Yeh RW
JACC Cardiovasc Interv; 2016 Dec; 9(23):2376-2386. PubMed ID: 27838271
[TBL] [Abstract][Full Text] [Related]
9. Bivalirudin Versus Heparin Monotherapy in Elderly Patients With Myocardial Infarction: A Prespecified Subgroup Analysis of the VALIDATE-SWEDEHEART Trial.
Wester A; Attar R; Mohammad MA; Isma N; James S; Omerovic E; Erlinge D; Koul S
Circ Cardiovasc Interv; 2020 Apr; 13(4):e008671. PubMed ID: 32216471
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of prehospital administration of unfractionated heparin, enoxaparin or bivalirudin in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: Insights from the ORBI registry.
Auffret V; Leurent G; Boulmier D; Bedossa M; Zabalawi A; Hacot JP; Coudert I; Filippi E; Castellant P; Rialan A; Rouault G; Druelles P; Boulanger B; Treuil J; Avez B; Le Guellec M; Gilard M; Le Breton H
Arch Cardiovasc Dis; 2016 Dec; 109(12):696-707. PubMed ID: 27818120
[TBL] [Abstract][Full Text] [Related]
11. Heparinase treatment of heparin-contaminated plasma from coronary artery bypass grafting patients enables reliable quantification of microRNAs.
Kondratov K; Kurapeev D; Popov M; Sidorova M; Minasian S; Galagudza M; Kostareva A; Fedorov A
Biomol Detect Quantif; 2016 Jun; 8():9-14. PubMed ID: 27335806
[TBL] [Abstract][Full Text] [Related]
12. Efficiency and safety of bivalirudin in patients undergoing emergency percutaneous coronary intervention via radial access: A subgroup analysis from the bivalirudin in acute myocardial infarction versus heparin and GPI plus heparin trial.
Wang H; Li Y; Cong H; Ding S; Liu B; Li L; Chen Y; Jia S; Jing Q; Zhao X; Liu H; Liang Z; Li J; Bao D; Han Y
Catheter Cardiovasc Interv; 2017 Jun; 89(7):1157-1165. PubMed ID: 27677411
[TBL] [Abstract][Full Text] [Related]
13. Myocardial reperfusion for acute myocardial infarction under an optimized antithrombotic medication: What can you expect in daily practice?
Pinelli S; Agrinier N; Bouchahda N; Metzdorf PA; Camenzind E; Popovic B
Cardiovasc Revasc Med; 2018; 19(7 Pt B):820-825. PubMed ID: 29555534
[TBL] [Abstract][Full Text] [Related]
14. Effect of postprocedural full-dose infusion of bivalirudin on acute stent thrombosis in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: Outcomes in a large real-world population.
Wang H; Liang Z; Li Y; Li B; Liu J; Hong X; Lu X; Wu J; Zhao W; Liu Q; An J; Li L; Pu F; Ming Q; Han Y
Cardiovasc Ther; 2017 Jun; 35(3):. PubMed ID: 28083915
[TBL] [Abstract][Full Text] [Related]
15. ST-segment resolution with bivalirudin versus heparin and routine glycoprotein IIb/IIIa inhibitors started in the ambulance in ST-segment elevation myocardial infarction patients transported for primary percutaneous coronary intervention: The EUROMAX ST-segment resolution substudy.
Van't Hof A; Giannini F; Ten Berg J; Tolsma R; Clemmensen P; Bernstein D; Coste P; Goldstein P; Zeymer U; Hamm C; Deliargyris E; Steg PG
Eur Heart J Acute Cardiovasc Care; 2017 Aug; 6(5):404-411. PubMed ID: 26250825
[TBL] [Abstract][Full Text] [Related]
16. One-Year Mortality for Bivalirudin vs Heparins Plus Optional Glycoprotein IIb/IIIa Inhibitor Treatment Started in the Ambulance for ST-Segment Elevation Myocardial Infarction: A Secondary Analysis of the EUROMAX Randomized Clinical Trial.
Fabris E; Kilic S; Van't Hof AWJ; Ten Berg J; Ayesta A; Zeymer U; Hamon M; Soulat L; Bernstein D; Anthopoulos P; Deliargyris EN; Steg PG
JAMA Cardiol; 2017 Jul; 2(7):791-796. PubMed ID: 28273285
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of RNA isolation methods for microRNA quantification in a range of clinical biofluids.
Roest HP; IJzermans JNM; van der Laan LJW
BMC Biotechnol; 2021 Aug; 21(1):48. PubMed ID: 34362351
[TBL] [Abstract][Full Text] [Related]
18. Comparative Analysis of Circulating Noncoding RNAs Versus Protein Biomarkers in the Detection of Myocardial Injury.
Schulte C; Barwari T; Joshi A; Theofilatos K; Zampetaki A; Barallobre-Barreiro J; Singh B; Sörensen NA; Neumann JT; Zeller T; Westermann D; Blankenberg S; Marber M; Liebetrau C; Mayr M
Circ Res; 2019 Jul; 125(3):328-340. PubMed ID: 31159652
[TBL] [Abstract][Full Text] [Related]
19. Heparin Versus Bivalirudin Monotherapy in the Setting of Primary Percutaneous Coronary Intervention for Patients With ST-Segment Elevation Myocardial Infarction.
Faulkenberg KD; Beavers JC; Finks SW
Ann Pharmacother; 2016 Feb; 50(2):141-51. PubMed ID: 26681442
[TBL] [Abstract][Full Text] [Related]
20. Circulating microRNAs in patients with ST-elevation myocardial infarction.
Eryılmaz U; Akgüllü Ç; Beşer N; Yıldız Ö; Kurt Ömürlü İ; Bozdoğan B
Anatol J Cardiol; 2016 Jun; 16(6):392-6. PubMed ID: 27282672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
